Blogs
Hostile Could Become the Name of the Biotech Game -- Seeking Alpha
<strong><a href='http://www.burrillreport.com/'>The Burrill Report</a>submits:</strong><p><em>By Marie Daghlian</em></p><p>This may become the year of the hostile takeover. First it was Astellas (<a href='http://seekingalpha.com/symbol/alpmf.pk' title='Astellas Pharma Inc.'>ALPMF.PK</a>) going
Vax views are not balanced
Home | Contact Us | Advertise | About Us | Privacy Policy | News Archive Medicine Politics Practice Ideas Other stuff Jobs Search [BLOG HOMEPAGE] Vax views are not balanced By Dr Annette Katelaris
Swine flu update: 23 reports of adverse reactions to swine flu vaccines — Irish Medical Times
February 3, 2012 Home Contact Us About Us Subscribe Advertising Terms of Use Privacy Policy Sitemap RSS Feeds Irish Medical Times News Opinion Features Editorial Letters Blogs Clinical Times MIMS Ireland Lifestyle Jobs Events Small ads You are here: Home / Blogs / Health service news and views /
Vaccine Decision Ignites Autism Debate « WebMD Newsroom
WebMD's editorial staff on the latest news from the world of health.
Irish Medical Times | The Irish Medical Times Blog | Swine flu update: Study shows benefit of
Search website: Home About us News Opinion Blogs Clinical Clinical Times MIMS Ireland Lifestyle Jobs Events Small ads Gallery Links Home » The Irish Medical Times Blog » Health service news and views » Swine flu update: Study shows benefit
Blog. Corporate Roundtable on Human DNA Vaccines
Research on DNA vaccines is one of the most promising areas of life science study. Advances in the field are rapidly being made in industry as well as academia. Recent news includes:[pg] [b]Vical's an
Sinovac Biotech Ltd. Q4 2009 Earnings Call Transcript -- Seeking Alpha
<p>Sinovac Biotech Ltd. (<a href='http://seekingalpha.com/symbol/sva' alt='Sinovac Biotech Ltd.' title='Sinovac Biotech Ltd.'>SVA</a>)</p><p>Q4 2009 Earnings Call Transcript</p><p>April 6, 2010 9:00 am ET</p><br/><a
Sanofi-Aventis Q4 2009 Earnings Call Transcript -- Seeking Alpha
<p><strong>Sanofi-Aventis</strong><strong></strong><strong>(</strong><strong>SNY</strong><strong>)</strong><strong></strong></p><p>Q4 2009 Earnings Call Transcript</p><p>February 10, 2010 8:00 am ET</p><br/><a
Glaxo-Intercell Deal Could Bring New Developments to Vaccine Market -- Seeking Alpha
<strong><a href='http://www.epvantage.com/'>EP Vantage</a>submits:</strong><p>GlaxoSmithKline (<a href='http://seekingalpha.com/symbol/gsk' title='More opinion and analysis of GSK'>GSK</a>) signaled its ongoing strong interest in the vaccines space Friday by announcing a deal with Intercell (<a
D.C. Vaccine Conference: Why Investors Should Stay Tuned -- Seeking Alpha
<p>On Monday and Tuesday of this week, the<strong>7th Annual Vaccines: All Things Considered Conference</strong>is taking place in Washington, DC.</p><p>Investors should keep an eye on this event, which serves as an one-stop destination for valuable updates and exposure on all aspects of vaccine
Refine by Content Type:
Refine by Source:
- blogs.webmd.com (16)
- seekingalpha.com (14)
- www.genengnews.com (4)
- www.6minutes.com.au (2)
- www.imt.ie (2)
- imt.ie (1)
